Intranasal dexmedetomidine sedation during intra-articular joint injections in pediatric populatio

Phase 1

• Conditions: All the patients from 1year to 18 years of age who have been diagnosed by a pediatric rheumatologist to have a joint inflammation needing intra-articular corticosteroid injection in 1 to 5 joints; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2016-002065-66-FI
• Lead Sponsor: Miikka Tervonen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11-02
• Last Update Posted: 14 November 2016

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

-Patients from 1year to 18 years of age
-A joint inflammation in 1-5 joints requiring intra-articular corticosteroid injection diagnosed by pediatric rheumatologist
Are the trial subjects under 18? yes
Number of subjects for this age range: 109
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 4
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients under the age of 1year and over the age of 18years are excluded as well as patients needing injection therapy to more than 5 joints.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified